Research, lived experience, and community around the gut-brain connection Not medical advice

Research

Peer-reviewed studies on gut microbiome treatments, summarized in plain language. Select a study to read its conclusion and why it matters, or filter by treatment, condition, topic, or study type.

40 studies

  • Does a diverse whole-food plant-based dietary intervention improve gut microbiome composition, gut symptoms, energy and hunger in healthy adults? A randomised controlled trial 2026 Randomized controlled trial
    Authors
    Creedon et al.
    Journal
    British Journal of Nutrition (2026)
    Study type
    Randomized controlled trial, 321 participants
    Finding
    Mixed

    Conclusion

    In 321 healthy adults with low fiber intake, six weeks of a 30-plant blend changed more gut bacteria species than croutons or a probiotic. The main comparison of whether those changes favored healthier species was not significant, though energy, happiness and some digestive symptoms improved slightly versus croutons.

    Why it matters

    Adds a randomized test of a plant-variety product, but the changes were small and their health meaning is unclear. The maker, ZOE, funded it and its staff and co-founders are authors; it was short, not fully blinded, and did not study mood disorders.

    • Dietary fiber
    • Microbial diversity
  • Brief Report: Can Fecal Microbiota Transplantation Treat Depression? 2026 Review
    Authors
    Benterkia and Blythe
    Journal
    JGH Open (2026)
    Study type
    Review
    Finding
    Mixed

    Conclusion

    This review of four human studies (two small randomized trials and two case reports) of FMT for depression found that the 15-person depression trial showed FMT was feasible and well tolerated, with no significant change in depression scores. The authors conclude the clinical evidence is still preliminary.

    Why it matters

    It gives a quick map of the earliest human work on FMT for depression, alongside supportive animal studies. It rests on a single-database, English-only search of papers since 2016, and a handful of very small studies.

    • Fecal microbiota transplantation (FMT)
    • Depression
  • The Impact of Diet on the Fecal Microbiota Transplantation Success in Patients with Gastrointestinal Diseases—A Literature Review 2025 Review
    Authors
    Komorniak et al.
    Journal
    Nutrients (2025)
    Study type
    Review
    Finding
    Mixed

    Conclusion

    In a review of nine human studies (18–165 participants) adding diet to fecal transplants for gut diseases, most reported added benefit, such as remission in 65.7% vs 35.5% of ulcerative colitis patients given an anti-inflammatory diet plus transplant versus standard therapy. One trial found no benefit from added fiber.

    Why it matters

    Summarizes early evidence that adding fiber or an anti-inflammatory diet may improve fecal transplant results, but the underlying studies are mostly small and short, several lacked a transplant-alone comparison, and the review searched only PubMed. The authors call for large randomized trials.

    • Fecal microbiota transplantation (FMT)
    • Dietary fiber
    • Mediterranean diet
    • Ulcerative colitis
    • Irritable bowel syndrome (IBS)
    • Microbial diversity
    • Short-chain fatty acids
  • Role of the microbiome in regulation of the immune system 2025 Review
    Authors
    Kim et al.
    Journal
    Allergology International (2025)
    Study type
    Review

    Conclusion

    This expert review of research on how gut and skin microbes shape the immune system reports consistent links between disrupted microbe communities and allergies, asthma, atopic dermatitis and worse COVID-19 outcomes. The authors say it remains unclear whether these changes drive immune problems or merely reflect them.

    Why it matters

    It summarizes how microbes and their by-products may guide immune development, and notes that probiotic trials often give mixed results while faecal microbiota transplants worked well for C. difficile infection. As an invited review with no described search method, it cannot show that treatments work, and one author declares industry consulting and funding.

    • Fecal microbiota transplantation (FMT)
    • Probiotics
    • Prebiotics
    • Allergic diseases (asthma, atopic dermatitis, food allergy)
    • Recurrent C. difficile infection
    • Short-chain fatty acids
    • Bifidobacterium
    • Microbial diversity
    • Bile acids
  • Pharmaco-psychiatry and gut microbiome: A systematic review of effects of psychotropic drugs for bipolar disorder 2025 Review
    Authors
    Bui et al.
    Journal
    medRxiv (2025)
    Study type
    Review
    Finding
    Mixed

    Conclusion

    Across 12 studies of adults with bipolar disorder, medicines such as quetiapine and lithium were linked to mixed changes in gut bacteria, with both helpful and potentially harmful species becoming more common. In one study, 63% of gut bacteria from medicated patients resisted multiple antibiotics, vs 42% in healthy people.

    Why it matters

    It offers what the authors call the first systematic overview of how bipolar medicines relate to gut bacteria, but the studies were small, mostly observational, varied in methods, and often involved several drugs at once. The authors did no statistical pooling, and this preprint has not been peer reviewed.

    • Psychotropic medications
    • Bipolar Disorder
    • Microbial diversity
    • Bifidobacterium
    • Antibiotic resistance
  • Nutritional optimization of fecal microbiota transplantation in humans: a scoping review 2025 Review
    Authors
    Teigen et al.
    Journal
    Gut Microbes (2025)
    Study type
    Review

    Conclusion

    Across 18 papers on diet in adults who had fecal transplants, the studies varied widely and gave little detail on diet. Some suggested that adding diet or fiber improved results, but the authors say diet's effect on transplant success remains unclear.

    Why it matters

    It maps what is known about diet before and after fecal transplants, and calls for better diet data in future trials. As a scoping review of mixed study designs, many with no control group or dietary intake data, it cannot show whether diet improves outcomes.

    • Fecal microbiota transplantation (FMT)
    • Dietary fiber
    • Mediterranean diet
    • Recurrent C. difficile infection
    • Irritable bowel syndrome (IBS)
    • Ulcerative colitis
    • Type 2 diabetes
    • Microbial diversity
  • Inflammatory and Immune Biomarkers in Mood Disorders: From Mechanistic Pathways to Clinical Translation 2025 Review
    Authors
    Pinzi et al.
    Journal
    Cells (2025)
    Study type
    Review
    Finding
    Mixed

    Conclusion

    This review of research on depression and bipolar disorder describes inflammation as marking a distinct subgroup of patients. Anti-inflammatory drugs helped mainly patients with high inflammation, and probiotics and prebiotics gave modest but inconsistent benefits.

    Why it matters

    The review links gut bacteria, inflammation and mood, but its treatment evidence comes from other studies and covers probiotics only briefly. It is a narrative review with no pooled analysis, and two authors declared drug-company consulting ties.

    • Depression
    • Bipolar Disorder
    • Microbial diversity
    • Short-chain fatty acids
    • Systemic inflammation
  • Clinical efficacy of fecal microbiota transplantation in alleviating depressive symptoms: a meta-analysis of randomized trials 2025 Meta-analysis
    Authors
    Zhang et al.
    Journal
    Frontiers in Psychiatry (2025)
    Study type
    Meta-analysis, 644 participants
    Finding
    Benefit

    Conclusion

    In 11 randomized trials with 644 people who had depressive symptoms, including people with irritable bowel syndrome, Parkinson's disease or major depression, FMT lowered depression scores more than placebo or standard drug treatment. The effect shrank when three outlying trials were left out and faded by 6 months.

    Why it matters

    It pools the randomized evidence on FMT for depressive symptoms, though only one included trial enrolled people with major depression. Limits: results varied widely between trials, and the authors rate the certainty of the evidence as low to very low.

    • Fecal microbiota transplantation (FMT)
    • Depression
    • Irritable bowel syndrome (IBS)
  • Bipolar Disorder can be Managed by FMT 2025 Review
    Authors
    Pushkala and Gupta
    Journal
    Clinical Trials and Case Studies (2025)
    Study type
    Review
    Finding
    Benefit

    Conclusion

    In this narrative review of gut bacteria and bipolar disorder, the authors describe two single-patient reports in which fecal transplants were followed by reported improvement, and conclude that transplants may be an option for treatment-resistant bipolar disorder.

    Why it matters

    Adds no new patient data. It summarizes earlier work, and the only transplant evidence it describes comes from single-patient reports with no comparison group. The authors say clinical trials are limited, and the article does not describe how studies were selected.

    • Fecal microbiota transplantation (FMT)
    • Bipolar Disorder
    • Short-chain fatty acids
    • Microbial diversity
  • What defines a healthy gut microbiome? 2024 Review
    Authors
    Van Hul et al.
    Journal
    Gut (2024)
    Study type
    Review

    Conclusion

    This expert review of gut microbiome research concludes there is still no agreed definition of a healthy gut microbiome. Markers such as diversity, what gut bacteria can do, and the chemicals they make each have limits, and the authors suggest function may say more about health than which species are present.

    Why it matters

    It adds a set of proposed markers and their limits rather than new data, and it tests no treatment. It is a narrative review with no stated method for choosing studies, and some authors declare patents and company ties.

    • Microbial diversity
    • Short-chain fatty acids
    • Bile acids
  • Safety and efficacy of fecal microbiota transplantation (FMT) as a modern adjuvant therapy in various diseases and disorders: a comprehensive literature review 2024 Review
    Authors
    Karimi et al.
    Journal
    Frontiers in Immunology (2024)
    Study type
    Review
    Finding
    Mixed

    Conclusion

    This literature review of published studies, not a new trial, concludes that fecal microbiota transplantation is generally safe and reports cure rates of 80–90%. Results were inconsistent in other conditions, including diabetes and psoriatic arthritis, where one trial found placebo did better.

    Why it matters

    It gives a broad overview but says nothing about how studies were searched for, selected or quality-checked, and it leans on case reports, small studies and animal work. Its headline cure rate is not broken down by condition.

    • Fecal microbiota transplantation (FMT)
    • Recurrent C. difficile infection
    • Ulcerative colitis
    • Irritable bowel syndrome (IBS)
    • Type 2 diabetes
    • Microbial diversity
    • Short-chain fatty acids
  • Potential effects of the most prescribed drugs on the microbiota-gut-brain-axis: A review 2024 Review
    Authors
    Garg and Mohajeri
    Journal
    Brain Research Bulletin (2024)
    Study type
    Review

    Conclusion

    In a review of published human studies of people taking metformin, statins, acid-reducing drugs, anti-inflammatory painkillers and antidepressants, each drug was linked to changes in gut bacteria, some rising and some falling. Some changes resembled those seen in depression, multiple sclerosis, Parkinson's and Alzheimer's, but the authors say the evidence is not yet strong enough for firm conclusions.

    Why it matters

    It adds a side-by-side comparison of how common drugs shift gut bacteria and how that overlaps with microbiome changes in brain diseases, but the overlap is a hypothesis. Limits: it summarizes small, varied studies (5–25 people for metformin) that often did not account for other medicines, diet or age.

    • Metformin
    • Statins
    • Proton-pump inhibitors (PPIs)
    • NSAIDs
    • Antidepressants
    • Depression
    • Multiple sclerosis
    • Parkinson's disease
    • Alzheimer's disease
    • Bifidobacterium
    • Prevotella
    • Microbial diversity
  • Is a vegetarian diet beneficial for bipolar disorder? Relationship between dietary patterns, exercise and pharmacological treatments with metabolic syndrome and course of disease in bipolar disorder 2024 Cross-sectional study
    Authors
    Gomes da Costa et al.
    Journal
    Acta Psychiatrica Scandinavica (2024)
    Study type
    Cross-sectional study, 66 participants
    Finding
    Benefit

    Conclusion

    In 66 people with bipolar disorder who were stable or mildly depressed, closer Mediterranean diet adherence went with better quality of life. A vegetarian-style eating pattern went with lower depression scores, better daily functioning, and lower weight and cholesterol.

    Why it matters

    One of few studies of diet in bipolar disorder. It compares people at one point in time, so it cannot show that diet caused the differences, and the group was small.

    • Mediterranean diet
    • Whole diet interventions
    • Bipolar Disorder
  • Advances in fecal microbiota transplantation for the treatment of diabetes mellitus 2024 Review
    Authors
    Zhang et al.
    Journal
    Frontiers in Cellular and Infection Microbiology (2024)
    Study type
    Review
    Finding
    Benefit

    Conclusion

    This review of mostly animal and small human studies of diabetes found that fecal transplants from healthy donors were reported to improve blood sugar and related measures, with no obvious harm reported. The authors say large randomized trials are still lacking.

    Why it matters

    It gathers the animal and early human evidence on fecal transplants for diabetes in one place. Its limits: no stated method for choosing studies, human studies described are small (1 to 61 patients), and the authors say larger trials, donor choice and dosing still need study.

    • Fecal microbiota transplantation (FMT)
    • Type 2 diabetes
    • Type 1 diabetes
    • Short-chain fatty acids
    • Bile acids
    • Microbial diversity
  • Safety and feasibility of faecal microbiota transplant for major depressive disorder: study protocol for a pilot randomised controlled trial 2023 Other
    Authors
    Green et al.
    Journal
    Pilot and Feasibility Studies (2023)
    Study type
    Other

    Conclusion

    This is a plan, not results: 15 adults with moderate-to-severe depression will be randomly assigned to four FMT or placebo enemas over four days, followed for 8 weeks plus 26 more weeks for safety. The main aims are to test whether this is feasible and safe.

    Why it matters

    It documents how this small pilot was designed, including a placebo enema and blinding, but reports no outcomes, so it cannot show whether FMT helps depression. Microbiome testing is company-supported.

    • Fecal microbiota transplantation (FMT)
    • Depression
  • Recipient-independent, high-accuracy FMT-response prediction and optimization in mice and humans 2023 Other
    Authors
    Shtossel et al.
    Journal
    Microbiome (2023)
    Study type
    Other

    Conclusion

    Using stool data from 12 mouse and human transplant cohorts plus 48 antibiotic-treated mice, a model based only on donor bacteria predicted recipients' post-transplant gut diversity, and donors predicted to yield higher diversity did so in mice. It predicted clinical improvement only modestly (about 0.7 on a scale where 0.5 is chance and 1 perfect).

    Why it matters

    It suggests donors might be chosen by their gut bacteria alone, without recipient information, but this is mostly a computer study on past data. Only mice were tested prospectively, no patients were transplanted with predicted donors, and the proposed bacterial mixtures exist only as simulations.

    • Fecal microbiota transplantation (FMT)
    • Recurrent C. difficile infection
    • Ulcerative colitis
    • Irritable bowel syndrome (IBS)
    • Inflammatory bowel disease (IBD)
    • Microbial diversity
  • Psychobiotics and fecal microbial transplantation for autism and attention-deficit/hyperactivity disorder: microbiome modulation and therapeutic mechanisms 2023 Review
    Authors
    Kwak et al.
    Journal
    Frontiers in Cellular and Infection Microbiology (2023)
    Study type
    Review
    Finding
    Mixed

    Conclusion

    This review of published studies in people with autism or attention-deficit/hyperactivity disorder (ADHD) lists probiotic and fecal transplant studies that reported fewer symptoms. The authors call the clinical evidence ambiguous and equivocal, and recommend double-blind randomized trials.

    Why it matters

    It gives non-specialists an overview of how probiotics and fecal transplants might act through the gut-brain link. Limits: it is a narrative review, much of the mechanism work comes from animals, and several cited human studies were open-label or single-patient reports.

    • Probiotics
    • Fecal microbiota transplantation (FMT)
    • Autism spectrum disorder (ASD)
    • Attention-deficit/hyperactivity disorder (ADHD)
    • Microbial diversity
    • Bifidobacterium
    • Prevotella
    • Short-chain fatty acids
  • Fecal microbiota transplantation ameliorates type 2 diabetes via metabolic remodeling of the gut microbiota in db/db mice 2023 Animal study
    Authors
    Chen et al.
    Journal
    BMJ Open Diabetes Research & Care (2023)
    Study type
    Animal study
    Finding
    Benefit

    Conclusion

    In 16 genetically diabetic mice, those given fecal transplants from healthy mice for 4 weeks had lower blood sugar, lower blood insulin and better glucose tolerance than mice given saline. Their gut bacteria also shifted toward those of the healthy donor mice.

    Why it matters

    It suggests possible explanations for how FMT works (changes in gut bacteria, blood chemicals, gut lining and inflammation), but these were linked to the improvement, not proven to cause it. The results come from small groups of one genetic mouse model, so they may not carry over to people.

    • Fecal microbiota transplantation (FMT)
    • Type 2 diabetes
    • Microbial diversity
  • Feasibility, Acceptability, and Safety of Faecal Microbiota Transplantation in the Treatment of Major Depressive Disorder: A Pilot Randomized Controlled Trial 2023 Randomized controlled trial
    Authors
    Green et al.
    Journal
    The Canadian Journal of Psychiatry (2023)
    Study type
    Randomized controlled trial, 15 participants

    Conclusion

    In 15 adults with moderate-to-severe major depression, 10 received faecal transplant enemas and 5 a placebo enema alongside their usual treatment. All 15 completed the 8 weeks, no serious or severe side effects were reported, and mild-to-moderate side effects were similar in both groups (a median of 2 per person).

    Why it matters

    The authors describe it as the first blinded, placebo-controlled trial of FMT for depression, and it supports larger studies. It was too small to show whether FMT works, and changes in participants' other treatments may have affected depression scores.

    • Fecal microbiota transplantation (FMT)
    • Depression
  • Characterization of gut microbiota profile in Iranian patients with bipolar disorder compared to healthy controls 2023 Cross-sectional study
    Authors
    Rashnaei et al.
    Journal
    Frontiers in Cellular and Infection Microbiology (2023)
    Study type
    Cross-sectional study, 60 participants

    Conclusion

    In 30 people with bipolar disorder and 30 healthy people in Iran, every bacterial group tested was present at different levels in the two groups. Bifidobacterium was lower and Lactobacillus higher in the bipolar group, which the authors suggest may point to a link with brain function.

    Why it matters

    Adds a first look at gut bacteria in bipolar disorder in an Iranian sample, and it partly matches earlier studies. It is a small one-time comparison that cannot show cause; diets varied and medication use was not analyzed.

    • Bipolar Disorder
    • Bifidobacterium
  • The Gut-Brain Axis: The effect of dysbiosis on mood disorders like anxiety and depression 2022 Review
    Authors
    Sangal
    Journal
    Journal of High School Science (2022)
    Study type
    Review
    Finding
    Mixed

    Conclusion

    This review of gut-brain research, drawing largely on mouse studies and some human trials, concludes that probiotics could help a subgroup of people with depression or anxiety. It notes that human trials have not been very successful, especially in severe depression.

    Why it matters

    It adds an overview linking gut bacteria to mood, but it cannot show that probiotics work: it has no stated method for choosing studies and leans heavily on mouse work. It also describes the evidence as both conclusive and disappointing in humans.

    • Probiotics
    • Fecal microbiota transplantation (FMT)
    • Prebiotics
    • Mediterranean diet
    • Depression
    • Anxiety
    • Short-chain fatty acids
    • Microbial diversity
    • Bifidobacterium
    • Lactic acid bacteria
  • Microbiota-targeted interventions for mental health 2022 Review
    Authors
    Berding and Cryan
    Journal
    Current Opinion in Psychiatry (2022)
    Study type
    Review
    Finding
    Mixed

    Conclusion

    This review of recent research on gut-targeted approaches for mental health found promising but early evidence, mainly for probiotics, prebiotics and diet as add-on treatments for mood and anxiety. Studies in patient groups are scarce, and the authors say probiotics alone are not yet supported for mood disorders.

    Why it matters

    Gives a broad overview of six approaches, and stresses that results may depend on strain, dose and a person's own gut bacteria. It is a narrative overview, many cited trials are small or in healthy people, and the authors declare ties to food and probiotic companies.

    • Probiotics
    • Prebiotics
    • Synbiotics
    • Postbiotics
    • Fecal microbiota transplantation (FMT)
    • Fermented foods
    • Whole diet interventions
    • Depression
    • Anxiety disorders
  • Health improvements of type 2 diabetic patients through diet and diet plus fecal microbiota transplantation 2022 Randomized controlled trial
    Authors
    Su et al.
    Journal
    Scientific Reports (2022)
    Study type
    Randomized controlled trial, 5 participants
    Finding
    Mixed

    Conclusion

    Adding three weekly rounds of oral FMT capsules to the same diet in 5 people with type 2 diabetes brought earlier weight loss and faster gut microbiome change (toward Prevotella), and HbA1c (6.9% to 5.9%) and systolic blood pressure (133 to 109 mmHg) fell by day 20. However, clinical changes did not differ significantly from the diet-only group, which the authors attribute to the small sample, and HbA1c partly rebounded by day 90.

    Why it matters

    An early test of FMT as an add-on to diet for type 2 diabetes: it suggests FMT may speed up microbiome change and soften the diet-related drop in microbial diversity, with no adverse reactions reported, but it shows no added clinical benefit yet. With only 5 FMT patients (3 dropped out) and no placebo, it is best treated as a pilot.

    • Fecal microbiota transplantation (FMT)
    • Probiotics
    • Prebiotics
    • Dietary fiber
    • Type 2 diabetes
    • Microbial diversity
    • Prevotella
    • Bifidobacterium
    • Sulfate-reducing bacteria
  • Health improvements of type 2 diabetic patients through diet and diet plus fecal microbiota transplantation 2022 Randomized controlled trial
    Authors
    Su et al.
    Journal
    Scientific Reports (2022)
    Study type
    Randomized controlled trial, 8 participants
    Finding
    Benefit

    Conclusion

    In 8 people with type 2 diabetes, 90 days of a diet supplemented with probiotics, prebiotic fiber and whole grains significantly lowered BMI (24.8 to 23.4), HbA1c (8.3% to 6.6%) and systolic blood pressure (135 to 118 mmHg) compared with baseline. Fasting blood glucose fell sharply during the first 20 days (9.6 to 6.7 mmol/L) and partly rebounded by day 90, while Bifidobacterium increased and the sulfate-reducing bacterium Bilophila decreased.

    Why it matters

    Supports the idea that a fiber- and probiotic-rich diet can improve blood sugar control in type 2 diabetes alongside a shift toward bacteria considered beneficial. But it is a very small open-label study with no untreated comparison group, the first 20 days were a supervised hospital stay, and it was funded in part by the company that makes the diet products.

    • Probiotics
    • Prebiotics
    • Dietary fiber
    • Type 2 diabetes
    • Microbial diversity
    • Bifidobacterium
    • Sulfate-reducing bacteria
    • Prevotella
  • Gut Microbiota – A Potential Contributor in the Pathogenesis of Bipolar Disorder 2022 Review
    Authors
    Zhang et al.
    Journal
    Frontiers in Neuroscience (2022)
    Study type
    Review

    Conclusion

    This review of 16 studies of people with bipolar disorder found that their gut bacteria often differed from those of healthy people, including lower diversity in several studies. The authors suggest gut-targeted treatments such as probiotics, diet and fecal transplant may help, but say the evidence is too early for clinical use.

    Why it matters

    It is a narrative summary rather than new analysis, and the studies it covers mostly compared patients with healthy people at one time point, so they cannot show cause. Treatment evidence rests on a handful of studies, including one case report, and many patients were already on medication.

    • Probiotics
    • Prebiotics
    • Mediterranean diet
    • Fecal microbiota transplantation (FMT)
    • Bipolar Disorder
    • Microbial diversity
    • Short-chain fatty acids
  • Faecal microbiota transplantation for bipolar disorder: A detailed case study 2022 Case report
    Authors
    Parker et al.
    Journal
    Bipolar Disorders (2022)
    Study type
    Case report, 1 participants
    Finding
    Benefit

    Conclusion

    In one man with bipolar II disorder, a nearly six-month FMT course (a colonoscopy dose, then enemas) was followed by much milder mood swings. He stopped his mood-stabilising medicine within two months and his second medicine, quetiapine, within six.

    Why it matters

    It adds a detailed, day-by-day record of a second published case of FMT for bipolar disorder. Limits: one person, no control group, mood ratings kept by the patient, and antibiotics, probiotics and diet changes came alongside FMT.

    • Fecal microbiota transplantation (FMT)
    • Bipolar Disorder
  • Adverse events in fecal microbiota transplantation: a systematic review and meta-analysis 2022 Meta-analysis
    Authors
    Rapoport et al.
    Journal
    Annals of Gastroenterology (2022)
    Study type
    Meta-analysis, 5099 participants

    Conclusion

    In 61 studies covering 5,099 patients treated with FMT for recurrent C. difficile infection, serious side effects linked to FMT occurred in under 1% of patients, while serious problems judged unrelated to FMT occurred in 2.9%. Minor side effects such as abdominal pain were each under 2%.

    Why it matters

    It pools the short-term safety record of FMT for this infection across many studies, though only 16 of the 61 were randomized and each study judged for itself whether a problem was caused by FMT. The authors note that long-term effects are not fully known.

    • Fecal microbiota transplantation (FMT)
    • Recurrent C. difficile infection
  • The safety and efficacy of fecal microbiota transplantation in a population with bipolar disorder during depressive episodes: study protocol for a pilot randomized controlled trial 2021 Other
    Authors
    Cooke et al.
    Journal
    Pilot and Feasibility Studies (2021)
    Study type
    Other

    Conclusion

    This is a plan, not results: adults with bipolar disorder in a depressive episode will be randomly assigned to receive donor stool or their own stool by colonoscopy and followed for 24 weeks. The plan is to recruit 60 people to test feasibility, safety and early signs of benefit.

    Why it matters

    It shows how a planned early trial of FMT in bipolar depression is designed, including a control group that receives its own stool. It reports no outcomes, so it cannot show whether FMT helps.

    • Fecal microbiota transplantation (FMT)
    • Bipolar Disorder
  • The Interplay between the Gut Microbiome and the Immune System in the Context of Infectious Diseases throughout Life and the Role of Nutrition in Optimizing Treatment Strategies 2021 Review
    Authors
    Wiertsema et al.
    Journal
    Nutrients (2021)
    Study type
    Review
    Finding
    Mixed

    Conclusion

    This review of research on the gut microbiome and immunity from infancy to old age describes how probiotics, prebiotics and dietary fiber may help prevent or treat infections. It notes that probiotic trial results conflict, and that differences between products and between people limit firm recommendations.

    Why it matters

    A narrative review with no stated search method, so it reflects the authors' choice of studies; much of the mechanism work it cites is in mice. The authors are employed by a food company (Danone Nutricia Research) and declare no conflict of interest.

    • Probiotics
    • Prebiotics
    • Dietary fiber
    • Infectious diseases
    • Short-chain fatty acids
  • Perturbations in Gut Microbiota Composition in Psychiatric Disorders: A Review and Meta-analysis 2021 Meta-analysis
    Authors
    Nikolova et al.
    Journal
    JAMA Psychiatry (2021)
    Study type
    Meta-analysis, 2948 participants

    Conclusion

    In 59 studies comparing adults with psychiatric disorders to controls, patients had modestly lower gut bacterial richness. Across depression, bipolar disorder, schizophrenia and anxiety, the studies linked these conditions to fewer anti-inflammatory, butyrate-producing bacteria and more pro-inflammatory ones, rather than to disorder-specific patterns.

    Why it matters

    The paper suggests gut bacteria differences are shared across several disorders rather than unique to each, which weakens the case for disorder-specific gut biomarkers. The studies were observational and mostly small, so cause and effect can't be shown, and psychiatric medication and region may explain some differences.

    • Depression
    • Bipolar Disorder
    • Schizophrenia
    • Anxiety disorders
    • Anorexia nervosa
    • Microbial diversity
    • Lactic acid bacteria
    • Bifidobacterium
  • Therapeutic Goods (Standard for Faecal Microbiota Transplant Products) (TGO 105) Order 2020 2020 Other
    Study type
    Other

    Conclusion

    This Australian legal standard sets rules for making faecal microbiota transplant products, including how donors are screened, how samples are tested, and how stool is processed and stored. It is a regulation, not a study, and reports no patient results.

    Why it matters

    It shows how these products are regulated in Australia but adds no evidence on whether they work or how safe they are for patients. Its rules cover manufacturing and donors only.

    • Fecal microbiota transplantation (FMT)
  • Mediterranean diet intervention alters the gut microbiome in older people reducing frailty and improving health status: the NU-AGE 1-year dietary intervention across five European countries 2020 Randomized controlled trial
    Authors
    Ghosh et al.
    Journal
    Gut (2020)
    Study type
    Randomized controlled trial, 612 participants
    Finding
    Mixed

    Conclusion

    In 612 older adults across five European countries who were non-frail or pre-frail, a year-long Mediterranean diet did not significantly change overall gut microbial diversity versus a control group. Closer adherence was linked to less diversity loss and to gut bacteria associated with lower inflammation and frailty markers.

    Why it matters

    It offers candidate bacteria that respond to a Mediterranean diet and hints the microbiome may mediate diet's health effects. Most associations were weak correlations among adherers, not trial-arm comparisons, and metabolite changes were predicted from sequencing rather than measured.

    • Mediterranean diet
    • Frailty
    • Microbial diversity
    • Bile acids
  • Fecal Microbiota Transplantation: Screening and Selection to Choose the Optimal Donor 2020 Review
    Authors
    Bibbò et al.
    Journal
    Journal of Clinical Medicine (2020)
    Study type
    Review

    Conclusion

    This narrative review of published studies found that fecal transplants are recommended only for recurrent C. difficile infection, where cure rates reach up to 90%, while evidence for ulcerative colitis, irritable bowel syndrome and metabolic disorders is promising but limited. Choosing donors by their gut microbes is not yet ready for routine use.

    Why it matters

    It brings together donor screening steps (interview, blood and stool tests) and early hints about choosing donors by microbial makeup. As a narrative review it reports no systematic search method, and much of the donor-matching evidence comes from small studies or mouse experiments.

    • Fecal microbiota transplantation (FMT)
    • Recurrent C. difficile infection
    • Irritable bowel syndrome (IBS)
    • Ulcerative colitis
    • Microbial diversity
  • The Effects of Dietary Improvement on Symptoms of Depression and Anxiety: A Meta-Analysis of Randomized Controlled Trials 2019 Meta-analysis
    Authors
    Firth et al.
    Journal
    Psychosomatic Medicine (2019)
    Study type
    Meta-analysis, 45826 participants
    Finding
    Benefit

    Conclusion

    Pooling 16 randomized trials with 45,826 adults, mostly without diagnosed depression, diet programs modestly reduced depressive symptoms compared with usual diet or other activities. They did not clearly reduce anxiety across 11 trials with 2,270 people.

    Why it matters

    Only one trial enrolled people with diagnosed depression, so the results mostly apply to mild or subthreshold symptoms. The trials differed widely and showed signs of publication bias, and benefits appeared in women but not men, based on few studies.

    • Whole diet interventions
    • Depression
    • Anxiety
  • The Gut Microbiome Composition Associates with Bipolar Disorder and Illness Severity 2017 Cross-sectional study
    Authors
    Evans et al.
    Journal
    Journal of Psychiatric Research (2017)
    Study type
    Cross-sectional study, 179 participants

    Conclusion

    In 115 people with bipolar disorder and 64 healthy controls, the overall mix of gut bacteria differed moderately, and Faecalibacterium was 34% lower in the bipolar group. Among those with bipolar disorder, more Faecalibacterium was linked to better self-reported physical health, depression, and sleep.

    Why it matters

    Adds early human evidence of a gut bacteria difference in bipolar disorder, echoing findings in depression, but it is a one-time snapshot that cannot show cause. Medications were not accounted for, outcomes were self-reported, and some authors declared industry consulting or research funding.

    • Bipolar Disorder
    • Faecalibacterium
  • Effect of Oral Capsule– vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection: A Randomized Clinical Trial 2017 Randomized controlled trial
    Authors
    Kao et al.
    Journal
    JAMA (2017)
    Study type
    Randomized controlled trial, 105 participants
    Finding
    Benefit

    Conclusion

    In 105 adults with repeated C. difficile infections, a single FMT prevented a recurrence over 12 weeks in 96% of those given capsules and 96% of those given it by colonoscopy. Capsules were not inferior, and more capsule patients called the experience not at all unpleasant (66% vs 44%).

    Why it matters

    It shows a swallowed capsule can work about as well as a colonoscopy, which is far less invasive, and that gut microbial diversity rose after both routes. Limits: no placebo group, patients knew their route, severe cases were excluded, and one author reported company grants.

    • Fecal microbiota transplantation (FMT)
    • Recurrent C. difficile infection
    • Microbial diversity
  • A randomised controlled trial of dietary improvement for adults with major depression (the 'SMILES' trial) 2017 Randomized controlled trial
    Authors
    Jacka et al.
    Journal
    BMC Medicine (2017)
    Study type
    Randomized controlled trial, 56 participants
    Finding
    Benefit

    Conclusion

    In 56 adults with moderate to severe depression who finished the trial, 12 weeks of dietitian support to eat a Mediterranean-style diet was followed by remission in 32% versus 8% with social support.

    Why it matters

    One of the few randomized tests of a diet for depression, but it was small and single-blind, and participants were also receiving other treatment. It did not study bipolar disorder.

    • Mediterranean diet
    • Depression
  • Understanding the mechanisms of faecal microbiota transplantation 2016 Review
    Authors
    Khoruts and Sadowsky
    Journal
    Nature Reviews Gastroenterology & Hepatology (2016)
    Study type
    Review

    Conclusion

    This expert review explains how donor stool may clear recurrent C. difficile infection: donor microbes compete with the germ, restore bile acids that block it, and support the gut's immune defences. The authors say benefit is clear only for this infection.

    Why it matters

    It sets out why FMT works for recurrent C. difficile infection, which helps in judging whether it could work for other conditions. The authors say the field is young and that other uses need more trials.

    • Fecal microbiota transplantation (FMT)
    • Recurrent C. difficile infection
    • Bile acids
    • Microbial diversity
    • Antibiotic resistance
  • High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome 2016 Cross-sectional study
    Authors
    De Filippis et al.
    Journal
    Gut (2016)
    Study type
    Cross-sectional study, 153 participants
    Finding
    Benefit

    Conclusion

    In 153 apparently healthy Italian adults (51 omnivores, 51 vegetarians, 51 vegans), closer adherence to a Mediterranean diet went with higher stool levels of short-chain fatty acids and lower urine levels of a gut-produced compound linked to heart disease. The stool trend also held among omnivores alone.

    Why it matters

    It links a Mediterranean-style diet, not only vegetarian or vegan eating, to gut metabolites tied to health. It is a one-time snapshot with self-recorded diet, so it cannot show cause, and no health outcomes were measured.

    • Mediterranean diet
    • Vegetarian and vegan diets
    • Short-chain fatty acids
    • Prevotella
    • Trimethylamine N-oxide (TMAO)
  • Fecal Microbiota Transplant Protocol for Clostridium Difficile Infection 2015 Other
    Authors
    Tauxe et al.
    Journal
    Lab Med (2015)
    Study type
    Other

    Conclusion

    This paper describes how one U.S. hospital prepares and performs fecal transplants for recurrent C. difficile infection, from donor screening to follow-up. The authors report more than 125 transplants there, with over 90% success (diarrhea stopped 4 weeks after the last treatment).

    Why it matters

    Adds practical detail on donor screening, stool preparation and delivery. The success figure is the center's own brief summary, with no comparison group or patient-level data, and FMT was still classed as investigational.

    • Fecal microbiota transplantation (FMT)
    • Recurrent C. difficile infection